Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants

Spremljeno u:
Bibliografski detalji
Izdano u:J Virol
Glavni autori: Mosier, Donald E., Picchio, Gastón R., Gulizia, Richard J., Sabbe, Rebecca, Poignard, Pascal, Picard, Laurent, Offord, Robin E., Thompson, Darren A., Wilken, Jill
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 1999
Teme:
Vaccines and Antiviral Agents
Online pristup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC104126/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10196243/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.5.3544-3550.1999
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items